Answers are grounded in this paper and cite their sources.
Modified vaccinia Ankara (MVA) is a promising vaccine vector due to its highly attenuated phenotype and good immunogenicity. However, obtaining a new recombinant MVA remains a tedious and laborious procedure involving many rounds of plaque purification. Recombinant MVA generation can be greatly improved and facilitated by different selection techniques. Here, we describe a comparison between techniques based on K1L, F13L and D4R genes.
No takes yet. Share an insight, caveat, or question.
Antoshkina et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: